Dr. Martens (LON:DOCS) Insider Giles Wilson Buys 232 Shares

Dr. Martens plc (LON:DOCS) insider Giles Wilson bought 232 shares of the stock in a transaction that occurred on Tuesday, April 14th. The shares were purchased at an average cost of GBX 65 per share, for a total transaction of £150.80.

Giles Wilson also recently made the following trade(s):

• On Wednesday, February 11th, Giles Wilson purchased 219 shares of Dr. Martens stock. The stock was bought at an average price of GBX 69 per share, with a total value of £151.11.

Dr. Martens Trading Up 0.9%

LON:DOCS opened at GBX 66.40 on Thursday. Dr. Martens plc has a 1-year low of GBX 49.53 and a 1-year high of GBX 100.87. The firm has a market capitalization of £641.91 million, a price-to-earnings ratio of 39.06, a price-to-earnings-growth ratio of 6.40 and a beta of 0.24. The company has a quick ratio of 1.13, a current ratio of 2.18 and a debt-to-equity ratio of 120.66. The stock has a fifty day simple moving average of GBX 65.50 and a 200 day simple moving average of GBX 75.75.

Analyst Ratings Changes

A number of brokerages have commented on DOCS. Berenberg Bank restated a “buy” rating on shares of Dr. Martens in a research report on Tuesday, January 27th. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Dr. Martens in a research note on Tuesday, February 3rd. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.